Loading chart…
PRE-MARKET
AstraZeneca Pharma India Limited, a biopharmaceutical company, manufactures, markets, and trades in pharmaceutical products in India and internationally. It provides medicines for cancers, including pancreatic cancer, certain blood cancers, and cancers within breast, lung, ovary, and prostate; rare diseases; and cardiovascular, renal and metabolism, and respiratory and immunology, as well as diabetes. The company serves distributors, hospitals, and government institutions.
AstraZeneca Pharma India Limited (ASTRAZEN) is listed on the NSE in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. The ASTRAZEN share price is ₹6,479.50 (+2.95% today), with a market capitalisation of ₹162B and a price-to-earnings (P/E) ratio of 91.1. MarketRipple tracks the ASTRAZEN investment thesis, the ripple-chain impact of market events on AstraZeneca Pharma India Limited, and the Healthcare sector outlook.
Open
₹6,507.50
High
₹6,583.00
Low
₹6,435.50
Prev. Close
₹6,294.00
52W High
₹9,469.50
52W Low
₹5,640.00
Day range
₹6,435.50–₹6,583.00
52-week range
₹5,640.00–₹9,469.50
Volume
2K
P/E
91.1
ROE
21.2%
D/E
0.13
Margin
6.8%
AstraZeneca Pharma India Limited (NSE: ASTRAZEN) is currently trading at ₹6,479.50 (+2.95%).
AstraZeneca Pharma India Limited's market capitalization is ₹162B.
AstraZeneca Pharma India Limited's price-to-earnings (P/E) ratio is 91.1.
AstraZeneca Pharma India Limited operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic).